PMC:7346000 / 183-558 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"25","span":{"begin":73,"end":81},"obj":"Species"},{"id":"36","span":{"begin":14,"end":18},"obj":"Disease"},{"id":"37","span":{"begin":95,"end":118},"obj":"Disease"},{"id":"38","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"39","span":{"begin":157,"end":180},"obj":"Disease"},{"id":"40","span":{"begin":281,"end":289},"obj":"Disease"},{"id":"41","span":{"begin":306,"end":358},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Tax:9606"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:D012128"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D055732"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:C000657245"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D055732"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:C000657245"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ess syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":14,"end":18},"obj":"Disease"},{"id":"T9","span":{"begin":105,"end":118},"obj":"Disease"},{"id":"T10","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"T11","span":{"begin":167,"end":180},"obj":"Disease"},{"id":"T12","span":{"begin":182,"end":186},"obj":"Disease"},{"id":"T13","span":{"begin":281,"end":289},"obj":"Disease"},{"id":"T14","span":{"begin":338,"end":358},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"ess syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":20,"end":23},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T2","span":{"begin":125,"end":127},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T3","span":{"begin":316,"end":326},"obj":"http://purl.obolibrary.org/obo/CL_0000066"}],"text":"ess syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predi"}